Physician profile
Devanshi Mody
NPI 1538470257
$14,417.87
in general payments reported to CMS, 2019-2025
66 companies · $3,133 in 2025
The $3,133 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,812 · 2020: $1,011 · 2021: $2,109 · 2022: $2,137 · 2023: $1,499 · 2024: $2,718 · 2025: $3,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,299 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,299.22 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,850.88 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,185.38 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Ucb, INC. | $1,036.75 | 2019-2025 | Nayzilam, Rystiggo, Briviact |
| Amgen INC. | $1,031.42 | 2019-2025 | Aimovig, Uplizna |
| Argenx US, INC. | $695.72 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Eisai INC. | $660.92 | 2019-2025 | |
| Sk Life Science, INC. | $571.22 | 2020-2025 | |
| Pfizer INC. | $542.56 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $514.17 | 2019-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $508.72 | 2019-2025 | |
| Neurelis, INC. | $442.09 | 2021-2025 | Valtoco |
| Lundbeck LLC | $423.06 | 2020-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $368.69 | 2020-2025 | Amyvid, Kisunla, Emgality |
| Allergan, INC. | $337.45 | 2019-2021 | |
| Csl Behring | $329.31 | 2019-2025 | Hizentra |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devanshi Mody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.